Elizabeth Alexander

Elizabeth Alexander's work experience includes:

- Vice President of Clinical Research and Development at Vir Biotechnology, Inc. since August 2021.

- Senior Medical Director at Vir Biotechnology, Inc. from June 2020 to August 2021.

- Senior Director of Clinical Development at Nabriva Therapeutics plc from March 2018 to May 2020, where they led and/or participated in the clinical/medical oversight of various development programs and provided advice on medical affairs and commercial strategy.

- Director of Clinical Development, Infectious Diseases Global Innovation Group at The Medicines Company from June 2014 to March 2018, where they led clinical trials and served as the primary medical monitor for a phase 3 trial.

- Assistant Professor Of Medicine at Weill Cornell Medicine from September 2012 to June 2014.

- Instructor In Medicine at Weill Cornell Medicine from September 2010 to September 2012.

Elizabeth Alexander's education history includes a Bachelor of Arts (BA) degree in Psychology (Neuroscience) from Stanford University (1995-1999). Elizabeth then pursued a Doctor of Medicine (MD) degree in Medicine from Joan & Sanford I. Weill Medical College of Cornell University (2000-2004). Elizabeth completed an Internship and Residency program in Internal Medicine at The Mount Sinai Hospital (2004-2007). Later, they enrolled in the Fellowship Program in Infectious Diseases at Joan & Sanford I. Weill Medical College of Cornell University (2007-2010). Finally, they attained a Master of Science (MS) degree in Clinical Investigation from Weill Cornell Graduate School of Medical Sciences (2010-2014).